R. Rota et al., PERIPHERAL EDEMA FORMATION WITH LACIDIPIN E, NITRENDIPINE AND NIFEDIPINE IN SPONTANEOUSLY HYPERTENSIVE RATS, Archives des maladies du coeur et des vaisseaux, 87(8), 1994, pp. 975-977
Introduction : Clinical studies suggest that lacidipine (LA) is better
tolerated than other DHP, in terms of peripheral edema. We evaluated
edema due to LA, nitrendipine (NT) and nifedipine (NF) in SHR. Methods
: Mean arterial pressure (MAP) was measured with an intra-femoral pro
be. Peripheral edema was determined (i) by the plasmatic distribution
of 14C-albumin, (ii) by Evans blue extravasation. Results : In bolus(i
p), LA, NT and NF had non different effects oil plasmatic ALB, i.e. 3,9 +/- 1,7 (DELTA % vs control at 60 min mean +/- SEM, n = 18). Evan
s blue extravasation (hind paws muscle = EBM) was positively correlate
d to MAP reduction (EBM = 0,1 x AMAP + 5,2 ; p < 0,025), without diffe
rences between the molecules. In chronical administration (9 days), at
comparable MAP decrases (31 +/- 2 mmHg), there was less edema formati
on with LA (0,05 mg/kg/j) than with NT (0,5 mg/kg/j) or NF (1,4 mg/kg/
j) : the variations of ALB were respectively (% vs control at 45 min
after tracer injection ; mean +/- SD) : + 5 % (n = 10) vs. 73 % (n = 1
4; p < 0,01 vs LA) and + 34 % (n = 10; p < 0,01 vs LA); no significant
change of hematocrit or plasma volume was noted. Conclusion : Our res
ults confirm, in SHR, that lacidipine induces a very moderate edema fo
rmation. This does not seem to be due to a renal effect, nor to an eff
ect on peripheral resistances. It was only observed in chronical admin
istration, which suggests that pharmacokinetic properties of lacidipin
e are involved.